跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TRAVATAN 40 MICROGRAMOS/ML COLIRIO EN SOLUCION - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
TRAVATAN 40 MICROGRAMOS/ML COLIRIO EN SOLUCION
Approved
STANDARD
TRAVATAN 40 MICROGRAMOS/ML COLIRIO EN SOLUCION
Novartis Europharm Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 24, 2023
Approval ID
f2e6aa41a1425c23
Company
Novartis Europharm Limited
Type
Standard
Approval Details
Approval Id
f2e6aa41a1425c23
Drug Cima Aemps Name
TRAVATAN 40 MICROGRAMOS/ML COLIRIO EN SOLUCION
Register Number
01199001IP2
Holder Company Name
Novartis Europharm Limited
Marketing Company Name
Difarmed S.L.
Holder Company Detail Path
/organization/novartis-europharm-limited
Authorization Date
2023-05-24
Dosage Form
COLIRIO EN SOLUCIÓN
Dose
40 µg/ml
Route Of Administration
VÍA OFTÁLMICA
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Novartis Europharm Limited
Company Detail Path
/organization/novartis-europharm-limited
Company Information
Pharmaceutical Company Name
NOVARTIS EUROPHARM LIMITED
Country Name
United Kingdom
City Name
camberley,country_gb
Address
200 Frimley Business Park
Active Ingredients
TRAVOPROST
40 µg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 24, 2023
Approval ID
f2e6aa41a1425c23
Type
Standard
Back to CIMA-AEMPS Approvals
